Fludarabine

Overview

Teva markets Fludarabine. The Summary of Product Characteristics, along with the Patient Information Leaflet for Fludarabine from Teva can be downloaded below, along with other information such as Frequently Asked Questions where applicable. For further information about Teva's medicine(s) contact Teva's Medical Information Service by email: medinfo@tevauk.com or telephone: 0207 540 7117.

Available as

  • Solution for Injection or Infusion

Date of preparation: August 2021
Reference: COB-GB-NP-00077

Date of preparation: August 2021
Reference: COB-GB-NP-00078